Skip to main content
Company record · Grimbergen
Belgian companySituation normaleSociété à responsabilité limitée

Dr. Katya Borman

Enterprise number
1014.541.707
VAT number
BE1014541707
Registered office
Leopold Luypaertstraat 244, 1850 Grimbergen
See the 2 companies at this address
Incorporated on
2 October 2024
Members only
Health score
Latest financial year
2025
m87-f model
Size
Not published
Workforce not declared
Equity
€56.6K
Financial year 2025
Net result
€49.4K
Financial year 2025

Profile

Official information from the CBE (FPS Economy).

Dr. Katya Borman is a Belgian company (Société à responsabilité limitée) whose registered office is established at 1850 Grimbergen. Its main activity falls under “Activités de médecine générale” (NACE 86210).

Legal form
Société à responsabilité limitée
Legal situation
Situation normale
Date of incorporation
2 October 2024
Main activity (NACE)
86210Activités de médecine générale

An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more

Secondary activities

1 additional NACE code declared.

Your risk analysis on this company

AML Company ran Dr. Katya Borman through your due diligence questionnaire. Here are the first findings.

  • What is the geographic exposure of the client and of its transactions?

    Belgium only· Registered office published in the register

  • What is the company's solvency and lifecycle status?

    Trading, no proceedings· Legal situation published in the register

The rest of the analysis

Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.

Run the full analysis

Log in

This preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.

Establishments

1 active establishment unit declared with the CBE.

Implantation
Grimbergen

1 establishment · 1 municipality

Registered office1 establishment
Registered office
Leopold Luypaertstraat 244
Map
Establishment2364.831.690
Leopold Luypaertstraat 244
Map

Finances & financial health

Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).

Zone Altman
Grade
Computed on
Financial trend

Equity & result

EquityResult
Key figures by financial year
Financial yearEquityResult
2025€56,607€49,421

Financial ratios

Solvency, liquidity and profitability, computed year by year from the filed annual accounts.

Solvency
79,1%
Financial year 2025

Equity / balance sheet total

Liquidity
5 x
Financial year 2025

Current assets / debts due within one year

Net margin
-

This year's filing does not carry the item the calculation needs.

Result for the year / turnover

Operating margin
-

This year's filing does not carry the item the calculation needs.

Operating result / turnover

Long-term debt
-

This year's filing does not carry the item the calculation needs.

Debts due after one year / balance sheet total

Return on equity
87,3%
Financial year 2025

Result for the year / equity

Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.

Filing history (1)
Financial yearFilingFiling typeModelSource
01/01/202531/12/202517/04/2026Initialm87-fBNB

Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.

Health score and detailed factors

The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.

Unlock

Notices in the Belgian Official Gazette

Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.

Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.

Frequently asked questions about Dr. Katya Borman

Quick answers on Dr. Katya Borman's identity, contact details and official CBE information.

What is Dr. Katya Borman's enterprise number (CBE)?
Dr. Katya Borman's official enterprise number with the Crossroads Bank for Enterprises (CBE) is 1014541707. This unique number identifies the company with every Belgian administration.
What is Dr. Katya Borman's VAT number?
Dr. Katya Borman's intra-Community VAT number is BE1014541707. It is the CBE number prefixed with “BE” and enables trade within the European Union.
Where is Dr. Katya Borman's registered office?
Dr. Katya Borman's registered office is located at Leopold Luypaertstraat 244, 1850 Grimbergen, Belgium. This address is the official one declared with the CBE.
What is Dr. Katya Borman's legal form?
Dr. Katya Borman is incorporated under the legal form “Société à responsabilité limitée”. This form determines its legal and tax regime and its publication duties towards the Belgian Official Gazette.
When was Dr. Katya Borman incorporated?
Dr. Katya Borman was entered in the Crossroads Bank for Enterprises on 2 October 2024. This date is the official start of activity declared with the CBE.
Is Dr. Katya Borman still active?
Yes, Dr. Katya Borman is currently listed as an active company with the Crossroads Bank for Enterprises (CBE).
What is Dr. Katya Borman's main activity?
Dr. Katya Borman's declared main activity is: Activités de médecine générale (NACE code 86210). This NACE code officially classifies the company in the European nomenclature of economic activities.
How many establishments does Dr. Katya Borman have?
Dr. Katya Borman declares 1 establishment unit registered with the CBE, on top of its registered office.
Has Dr. Katya Borman filed its annual accounts?
Yes. Dr. Katya Borman's latest annual accounts were filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) on 17 April 2026, for the financial year ended 31 December 2025. The filings can be consulted publicly with the NBB.
Which official notices concern Dr. Katya Borman?
1 official notice about Dr. Katya Borman is available in the Belgian Official Gazette: incorporation, changes to the articles, appointments, dissolutions. Every one of these acts is listed on this page with a link to the official PDF.
Is Dr. Katya Borman subject to anti-money-laundering obligations in Belgium?
On the face of it, no. Dr. Katya Borman's declared activity is not among the professions expressly covered by the Act of 18 September 2017. This general information is not legal advice.

Company timeline

Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.

Timeline
2 events
Filter the timeline by event type

10 AI-analysed dimensions are not shown.

  1. 2026
    1. 17 April 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m87-fFiled accounts2026-00084354
  2. 2024
    1. 4 October 2024IncorporationView the notice24433810

Registry record since 7 September 2026

The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.

AI insights · Pro AI plan

AI extraction of strategic AML data

The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.

  • Legal life
  • Restructuring
  • Capital
  • Legal form
  • Incorporation
  • Directors
  • Beneficial owners
  • Registered office
  • Company name
  • Notarial deeds
AML Company

Step it up
Full analysis unlocked.

Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.

    We respect your privacy

    We use cookies that are essential to running the site and, with your consent, anonymised audience-measurement cookies (hosted in the EU) to improve our services. Learn more.